Covid-19 assays and studies

Services

We are ready to answer your questions and provide guidance.

covid-19 ASSAYS and studies

IITRI is in custody of a SARS-CoV-2 strain responsible for COVID-19.

We now offer both in vitro and in vivo options for testing your candidates for the inhibition of SARS-CoV-2 as well as efficacy::

– Vero cell SARS-CoV-2 assays are conducted in BSL-3 containment to determine efficacy (cell survival endpoints being EC50 and TC50). Vero cells are infected with the SARS-CoV-2 virus in 96 well plates and 50% are treated with your test article at various concentrations.

– Testing of surface disinfectant sprays and sanitizers against the SARS-CoV-2 strain. IITRI is currently conducting this type of testing based on a standard industry protocol.

– COVID-19 Ferret model studies to determine changes in viral load and shedding after intranasal administration of the SARS-CoV-2 virus. Therefore this model is a SARS-CoV-2 infection model. Intranasal, inhaled (inhalation) and other routes of administration are offered for dosing your test article.

IITRI has established itself as a leading COVID-19 CRO and due to the importance for this testing during the pandemic, has made provisions to turn these assays and studies around rapidly.

GO BACK